Русский

Pharmaceutical Industry Information Portal

HomeTagsPAXLOVID

All posts by tag

PAXLOVID

World Pharma News

China Meheco signs deal with Pfizer to supply Covid-19 pill

Techno -
China Meheco Group Co Ltd signed an agreement with Pfizer Inc to supply the latter's COVID-19 treatment Paxlovid in the Chinese mainland in 2022,...
World Pharma News

China approves Pfizer’s Covid-19 pill Paxlovid

Techno -
China's medical products regulator said on Saturday it has given conditional approval for Pfizer's COVID-19 drug Paxlovid, making it the first oral pill specifically...
Regulatory News

Pfizer Covid Pill Europe’s First Approved Oral Treatment Against Covid

Techno -
Pfizer announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) issued a positive opinion recommending the...
World Pharma News

European Medicines Agency receives application for conditional marketing authorisation for Paxlovid

Techno -
EMA has started evaluating an application for a conditional marketing authorisation for the oral antiviral medicine Paxlovid (PF-07321332 and ritonavir). The applicant is Pfizer...
Newsletter

Pfizer Receives U.S. FDA Emergency Use Authorization for Novel COVID-19 Oral Antiviral Treatment

Techno -
Pfizer Inc. announced that the U.S. Food and Drug Administration (FDA) has authorized the emergency use of PAXLOVID™ (nirmatrelvir tablets and ritonavir tablets)...
spot_img

Expert Articles

spot_img

Information Internet project PharmProm.Net dedicated to the pharmaceutical industry in the world. It contains a contact base of organizations, enterprises, companies associated with the pharmaceutical market. The editorial staff of the PharmProm.Net portal offers cooperation in the field of information promotion and advertising in the pharmaceutical market.

Read our Russian-language online magazine

Categories